ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-lasting Interferon Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18L9385
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Long lasting Interferon Market Insights Forecast to 2028
BUY CHAPTERS

Global Long-lasting Interferon Market Research Report 2025

Code: QYRE-Auto-18L9385
Report
July 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Anke Biotechnology
Bayer
Merck KGaA
Tri-Prime
Kawin
Genzon Pharma
Novartis
Biogen
Harbin Pharmaceutical
Zydus Cadila
Huaxin Biotechnology
Bristol–Myers Squibb
Gilead Sciences
AbbVie
Teva Pharmaceuticals

Long-lasting Interferon Market Size

The global market for Long-lasting Interferon was valued at US$ 2469 million in the year 2024 and is projected to reach a revised size of US$ 3007 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Long-lasting Interferon Market

Long-lasting Interferon Market

Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
The Long-lasting Interferon market represents a crucial and evolving segment within the pharmaceutical industry, characterized by the production and distribution of interferon-based medications that have been modified for prolonged therapeutic effects. These medications play a pivotal role in the treatment of various medical conditions, including viral infections like hepatitis C and certain types of cancers. The development of long-lasting interferon formulations, often pegylated interferon, has significantly improved patient outcomes by reducing the frequency of dosing while maintaining therapeutic efficacy. Key drivers behind the market"s growth include the persistent prevalence of viral infections, the increasing incidence of certain cancers, and ongoing research into the potential applications of interferon-based therapies in various immunological and autoimmune disorders. Moreover, the long-lasting interferon market has seen innovations in drug delivery systems, enabling more convenient administration and improving patient compliance. As the medical community continues to explore the therapeutic potential of interferons and develop advanced formulations, the Long-lasting Interferon market is expected to witness ongoing expansion, providing hope for improved treatments and outcomes in a range of medical conditions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-lasting Interferon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-lasting Interferon.
The Long-lasting Interferon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-lasting Interferon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-lasting Interferon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-lasting Interferon Market Report

Report Metric Details
Report Name Long-lasting Interferon Market
Accounted market size in year US$ 2469 million
Forecasted market size in 2031 US$ 3007 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Low Concentration
  • High Concentration
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Anke Biotechnology, Bayer, Merck KGaA, Tri-Prime, Kawin, Genzon Pharma, Novartis, Biogen, Harbin Pharmaceutical, Zydus Cadila, Huaxin Biotechnology, Bristol Myers Squibb, Gilead Sciences, AbbVie, Teva Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-lasting Interferon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-lasting Interferon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Long-lasting Interferon Market growing?

Ans: The Long-lasting Interferon Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Long-lasting Interferon Market size in 2031?

Ans: The Long-lasting Interferon Market size in 2031 will be US$ 3007 million.

Who are the main players in the Long-lasting Interferon Market report?

Ans: The main players in the Long-lasting Interferon Market are Roche, Anke Biotechnology, Bayer, Merck KGaA, Tri-Prime, Kawin, Genzon Pharma, Novartis, Biogen, Harbin Pharmaceutical, Zydus Cadila, Huaxin Biotechnology, Bristol Myers Squibb, Gilead Sciences, AbbVie, Teva Pharmaceuticals

What are the Application segmentation covered in the Long-lasting Interferon Market report?

Ans: The Applications covered in the Long-lasting Interferon Market report are Hepatitis, Multiple Sclerosis, Others

What are the Type segmentation covered in the Long-lasting Interferon Market report?

Ans: The Types covered in the Long-lasting Interferon Market report are Low Concentration, High Concentration

Recommended Reports

Antiviral Drugs & Therapy

Interferon & Long-acting Biologics

Vaccines & Immune Therapy

1 Long-lasting Interferon Market Overview
1.1 Product Definition
1.2 Long-lasting Interferon by Type
1.2.1 Global Long-lasting Interferon Market Value Comparison by Type (2024 VS 2031)
1.2.2 Low Concentration
1.2.3 High Concentration
1.3 Long-lasting Interferon by Application
1.3.1 Global Long-lasting Interferon Market Value by Application (2024 VS 2031)
1.3.2 Hepatitis
1.3.3 Multiple Sclerosis
1.3.4 Others
1.4 Global Long-lasting Interferon Market Size Estimates and Forecasts
1.4.1 Global Long-lasting Interferon Revenue 2020-2031
1.4.2 Global Long-lasting Interferon Sales 2020-2031
1.4.3 Global Long-lasting Interferon Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Long-lasting Interferon Market Competition by Manufacturers
2.1 Global Long-lasting Interferon Sales Market Share by Manufacturers (2020-2025)
2.2 Global Long-lasting Interferon Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Long-lasting Interferon Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Long-lasting Interferon, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-lasting Interferon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-lasting Interferon, Product Type & Application
2.7 Global Key Manufacturers of Long-lasting Interferon, Date of Enter into This Industry
2.8 Global Long-lasting Interferon Market Competitive Situation and Trends
2.8.1 Global Long-lasting Interferon Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-lasting Interferon Players Market Share by Revenue
2.8.3 Global Long-lasting Interferon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-lasting Interferon Market Scenario by Region
3.1 Global Long-lasting Interferon Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Long-lasting Interferon Sales by Region: 2020-2031
3.2.1 Global Long-lasting Interferon Sales by Region: 2020-2025
3.2.2 Global Long-lasting Interferon Sales by Region: 2026-2031
3.3 Global Long-lasting Interferon Revenue by Region: 2020-2031
3.3.1 Global Long-lasting Interferon Revenue by Region: 2020-2025
3.3.2 Global Long-lasting Interferon Revenue by Region: 2026-2031
3.4 North America Long-lasting Interferon Market Facts & Figures by Country
3.4.1 North America Long-lasting Interferon Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Long-lasting Interferon Sales by Country (2020-2031)
3.4.3 North America Long-lasting Interferon Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Long-lasting Interferon Market Facts & Figures by Country
3.5.1 Europe Long-lasting Interferon Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Long-lasting Interferon Sales by Country (2020-2031)
3.5.3 Europe Long-lasting Interferon Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-lasting Interferon Market Facts & Figures by Region
3.6.1 Asia Pacific Long-lasting Interferon Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Long-lasting Interferon Sales by Region (2020-2031)
3.6.3 Asia Pacific Long-lasting Interferon Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Long-lasting Interferon Market Facts & Figures by Country
3.7.1 Latin America Long-lasting Interferon Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Long-lasting Interferon Sales by Country (2020-2031)
3.7.3 Latin America Long-lasting Interferon Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-lasting Interferon Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-lasting Interferon Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Long-lasting Interferon Sales by Country (2020-2031)
3.8.3 Middle East and Africa Long-lasting Interferon Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Long-lasting Interferon Sales by Type (2020-2031)
4.1.1 Global Long-lasting Interferon Sales by Type (2020-2025)
4.1.2 Global Long-lasting Interferon Sales by Type (2026-2031)
4.1.3 Global Long-lasting Interferon Sales Market Share by Type (2020-2031)
4.2 Global Long-lasting Interferon Revenue by Type (2020-2031)
4.2.1 Global Long-lasting Interferon Revenue by Type (2020-2025)
4.2.2 Global Long-lasting Interferon Revenue by Type (2026-2031)
4.2.3 Global Long-lasting Interferon Revenue Market Share by Type (2020-2031)
4.3 Global Long-lasting Interferon Price by Type (2020-2031)
5 Segment by Application
5.1 Global Long-lasting Interferon Sales by Application (2020-2031)
5.1.1 Global Long-lasting Interferon Sales by Application (2020-2025)
5.1.2 Global Long-lasting Interferon Sales by Application (2026-2031)
5.1.3 Global Long-lasting Interferon Sales Market Share by Application (2020-2031)
5.2 Global Long-lasting Interferon Revenue by Application (2020-2031)
5.2.1 Global Long-lasting Interferon Revenue by Application (2020-2025)
5.2.2 Global Long-lasting Interferon Revenue by Application (2026-2031)
5.2.3 Global Long-lasting Interferon Revenue Market Share by Application (2020-2031)
5.3 Global Long-lasting Interferon Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Long-lasting Interferon Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Anke Biotechnology
6.2.1 Anke Biotechnology Company Information
6.2.2 Anke Biotechnology Description and Business Overview
6.2.3 Anke Biotechnology Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Anke Biotechnology Long-lasting Interferon Product Portfolio
6.2.5 Anke Biotechnology Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Long-lasting Interferon Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck KGaA Long-lasting Interferon Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 Tri-Prime
6.5.1 Tri-Prime Company Information
6.5.2 Tri-Prime Description and Business Overview
6.5.3 Tri-Prime Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tri-Prime Long-lasting Interferon Product Portfolio
6.5.5 Tri-Prime Recent Developments/Updates
6.6 Kawin
6.6.1 Kawin Company Information
6.6.2 Kawin Description and Business Overview
6.6.3 Kawin Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kawin Long-lasting Interferon Product Portfolio
6.6.5 Kawin Recent Developments/Updates
6.7 Genzon Pharma
6.7.1 Genzon Pharma Company Information
6.7.2 Genzon Pharma Description and Business Overview
6.7.3 Genzon Pharma Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Genzon Pharma Long-lasting Interferon Product Portfolio
6.7.5 Genzon Pharma Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Company Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novartis Long-lasting Interferon Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Biogen
6.9.1 Biogen Company Information
6.9.2 Biogen Description and Business Overview
6.9.3 Biogen Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biogen Long-lasting Interferon Product Portfolio
6.9.5 Biogen Recent Developments/Updates
6.10 Harbin Pharmaceutical
6.10.1 Harbin Pharmaceutical Company Information
6.10.2 Harbin Pharmaceutical Description and Business Overview
6.10.3 Harbin Pharmaceutical Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Harbin Pharmaceutical Long-lasting Interferon Product Portfolio
6.10.5 Harbin Pharmaceutical Recent Developments/Updates
6.11 Zydus Cadila
6.11.1 Zydus Cadila Company Information
6.11.2 Zydus Cadila Description and Business Overview
6.11.3 Zydus Cadila Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zydus Cadila Long-lasting Interferon Product Portfolio
6.11.5 Zydus Cadila Recent Developments/Updates
6.12 Huaxin Biotechnology
6.12.1 Huaxin Biotechnology Company Information
6.12.2 Huaxin Biotechnology Description and Business Overview
6.12.3 Huaxin Biotechnology Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Huaxin Biotechnology Long-lasting Interferon Product Portfolio
6.12.5 Huaxin Biotechnology Recent Developments/Updates
6.13 Bristol Myers Squibb
6.13.1 Bristol Myers Squibb Company Information
6.13.2 Bristol Myers Squibb Description and Business Overview
6.13.3 Bristol Myers Squibb Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bristol Myers Squibb Long-lasting Interferon Product Portfolio
6.13.5 Bristol Myers Squibb Recent Developments/Updates
6.14 Gilead Sciences
6.14.1 Gilead Sciences Company Information
6.14.2 Gilead Sciences Description and Business Overview
6.14.3 Gilead Sciences Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Gilead Sciences Long-lasting Interferon Product Portfolio
6.14.5 Gilead Sciences Recent Developments/Updates
6.15 AbbVie
6.15.1 AbbVie Company Information
6.15.2 AbbVie Description and Business Overview
6.15.3 AbbVie Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.15.4 AbbVie Long-lasting Interferon Product Portfolio
6.15.5 AbbVie Recent Developments/Updates
6.16 Teva Pharmaceuticals
6.16.1 Teva Pharmaceuticals Company Information
6.16.2 Teva Pharmaceuticals Description and Business Overview
6.16.3 Teva Pharmaceuticals Long-lasting Interferon Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Teva Pharmaceuticals Long-lasting Interferon Product Portfolio
6.16.5 Teva Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-lasting Interferon Industry Chain Analysis
7.2 Long-lasting Interferon Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-lasting Interferon Production Mode & Process Analysis
7.4 Long-lasting Interferon Sales and Marketing
7.4.1 Long-lasting Interferon Sales Channels
7.4.2 Long-lasting Interferon Distributors
7.5 Long-lasting Interferon Customer Analysis
8 Long-lasting Interferon Market Dynamics
8.1 Long-lasting Interferon Industry Trends
8.2 Long-lasting Interferon Market Drivers
8.3 Long-lasting Interferon Market Challenges
8.4 Long-lasting Interferon Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Anke Biotechnology
Bayer
Merck KGaA
Tri-Prime
Kawin
Genzon Pharma
Novartis
Biogen
Harbin Pharmaceutical
Zydus Cadila
Huaxin Biotechnology
Bristol–Myers Squibb
Gilead Sciences
AbbVie
Teva Pharmaceuticals
List of Tables
 Table 1. Global Long-lasting Interferon Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Long-lasting Interferon Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Long-lasting Interferon Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Long-lasting Interferon Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Long-lasting Interferon Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Long-lasting Interferon Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Long-lasting Interferon Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Long-lasting Interferon Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Long-lasting Interferon, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-lasting Interferon, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-lasting Interferon, Product Type & Application
 Table 12. Global Key Manufacturers of Long-lasting Interferon, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-lasting Interferon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-lasting Interferon as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-lasting Interferon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Long-lasting Interferon Sales by Region (2020-2025) & (K Units)
 Table 18. Global Long-lasting Interferon Sales Market Share by Region (2020-2025)
 Table 19. Global Long-lasting Interferon Sales by Region (2026-2031) & (K Units)
 Table 20. Global Long-lasting Interferon Sales Market Share by Region (2026-2031)
 Table 21. Global Long-lasting Interferon Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Long-lasting Interferon Revenue Market Share by Region (2020-2025)
 Table 23. Global Long-lasting Interferon Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Long-lasting Interferon Revenue Market Share by Region (2026-2031)
 Table 25. North America Long-lasting Interferon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Long-lasting Interferon Sales by Country (2020-2025) & (K Units)
 Table 27. North America Long-lasting Interferon Sales by Country (2026-2031) & (K Units)
 Table 28. North America Long-lasting Interferon Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Long-lasting Interferon Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Long-lasting Interferon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Long-lasting Interferon Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Long-lasting Interferon Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Long-lasting Interferon Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Long-lasting Interferon Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Long-lasting Interferon Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Long-lasting Interferon Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Long-lasting Interferon Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Long-lasting Interferon Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Long-lasting Interferon Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Long-lasting Interferon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Long-lasting Interferon Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Long-lasting Interferon Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Long-lasting Interferon Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Long-lasting Interferon Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Long-lasting Interferon Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Long-lasting Interferon Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Long-lasting Interferon Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Long-lasting Interferon Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Long-lasting Interferon Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Long-lasting Interferon Sales (K Units) by Type (2020-2025)
 Table 51. Global Long-lasting Interferon Sales (K Units) by Type (2026-2031)
 Table 52. Global Long-lasting Interferon Sales Market Share by Type (2020-2025)
 Table 53. Global Long-lasting Interferon Sales Market Share by Type (2026-2031)
 Table 54. Global Long-lasting Interferon Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Long-lasting Interferon Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Long-lasting Interferon Revenue Market Share by Type (2020-2025)
 Table 57. Global Long-lasting Interferon Revenue Market Share by Type (2026-2031)
 Table 58. Global Long-lasting Interferon Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Long-lasting Interferon Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Long-lasting Interferon Sales (K Units) by Application (2020-2025)
 Table 61. Global Long-lasting Interferon Sales (K Units) by Application (2026-2031)
 Table 62. Global Long-lasting Interferon Sales Market Share by Application (2020-2025)
 Table 63. Global Long-lasting Interferon Sales Market Share by Application (2026-2031)
 Table 64. Global Long-lasting Interferon Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Long-lasting Interferon Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Long-lasting Interferon Revenue Market Share by Application (2020-2025)
 Table 67. Global Long-lasting Interferon Revenue Market Share by Application (2026-2031)
 Table 68. Global Long-lasting Interferon Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Long-lasting Interferon Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Long-lasting Interferon Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Anke Biotechnology Company Information
 Table 76. Anke Biotechnology Description and Business Overview
 Table 77. Anke Biotechnology Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Anke Biotechnology Long-lasting Interferon Product
 Table 79. Anke Biotechnology Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Long-lasting Interferon Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Merck KGaA Company Information
 Table 86. Merck KGaA Description and Business Overview
 Table 87. Merck KGaA Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck KGaA Long-lasting Interferon Product
 Table 89. Merck KGaA Recent Developments/Updates
 Table 90. Tri-Prime Company Information
 Table 91. Tri-Prime Description and Business Overview
 Table 92. Tri-Prime Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Tri-Prime Long-lasting Interferon Product
 Table 94. Tri-Prime Recent Developments/Updates
 Table 95. Kawin Company Information
 Table 96. Kawin Description and Business Overview
 Table 97. Kawin Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Kawin Long-lasting Interferon Product
 Table 99. Kawin Recent Developments/Updates
 Table 100. Genzon Pharma Company Information
 Table 101. Genzon Pharma Description and Business Overview
 Table 102. Genzon Pharma Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Genzon Pharma Long-lasting Interferon Product
 Table 104. Genzon Pharma Recent Developments/Updates
 Table 105. Novartis Company Information
 Table 106. Novartis Description and Business Overview
 Table 107. Novartis Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Novartis Long-lasting Interferon Product
 Table 109. Novartis Recent Developments/Updates
 Table 110. Biogen Company Information
 Table 111. Biogen Description and Business Overview
 Table 112. Biogen Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Biogen Long-lasting Interferon Product
 Table 114. Biogen Recent Developments/Updates
 Table 115. Harbin Pharmaceutical Company Information
 Table 116. Harbin Pharmaceutical Description and Business Overview
 Table 117. Harbin Pharmaceutical Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Harbin Pharmaceutical Long-lasting Interferon Product
 Table 119. Harbin Pharmaceutical Recent Developments/Updates
 Table 120. Zydus Cadila Company Information
 Table 121. Zydus Cadila Description and Business Overview
 Table 122. Zydus Cadila Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zydus Cadila Long-lasting Interferon Product
 Table 124. Zydus Cadila Recent Developments/Updates
 Table 125. Huaxin Biotechnology Company Information
 Table 126. Huaxin Biotechnology Description and Business Overview
 Table 127. Huaxin Biotechnology Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Huaxin Biotechnology Long-lasting Interferon Product
 Table 129. Huaxin Biotechnology Recent Developments/Updates
 Table 130. Bristol Myers Squibb Company Information
 Table 131. Bristol Myers Squibb Description and Business Overview
 Table 132. Bristol Myers Squibb Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Bristol Myers Squibb Long-lasting Interferon Product
 Table 134. Bristol Myers Squibb Recent Developments/Updates
 Table 135. Gilead Sciences Company Information
 Table 136. Gilead Sciences Description and Business Overview
 Table 137. Gilead Sciences Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Gilead Sciences Long-lasting Interferon Product
 Table 139. Gilead Sciences Recent Developments/Updates
 Table 140. AbbVie Company Information
 Table 141. AbbVie Description and Business Overview
 Table 142. AbbVie Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. AbbVie Long-lasting Interferon Product
 Table 144. AbbVie Recent Developments/Updates
 Table 145. Teva Pharmaceuticals Company Information
 Table 146. Teva Pharmaceuticals Description and Business Overview
 Table 147. Teva Pharmaceuticals Long-lasting Interferon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Teva Pharmaceuticals Long-lasting Interferon Product
 Table 149. Teva Pharmaceuticals Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Long-lasting Interferon Distributors List
 Table 153. Long-lasting Interferon Customers List
 Table 154. Long-lasting Interferon Market Trends
 Table 155. Long-lasting Interferon Market Drivers
 Table 156. Long-lasting Interferon Market Challenges
 Table 157. Long-lasting Interferon Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-lasting Interferon
 Figure 2. Global Long-lasting Interferon Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-lasting Interferon Market Share by Type: 2024 & 2031
 Figure 4. Low Concentration Product Picture
 Figure 5. High Concentration Product Picture
 Figure 6. Global Long-lasting Interferon Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Long-lasting Interferon Market Share by Application: 2024 & 2031
 Figure 8. Hepatitis
 Figure 9. Multiple Sclerosis
 Figure 10. Others
 Figure 11. Global Long-lasting Interferon Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Long-lasting Interferon Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Long-lasting Interferon Sales (2020-2031) & (K Units)
 Figure 14. Global Long-lasting Interferon Average Price (US$/Unit) & (2020-2031)
 Figure 15. Long-lasting Interferon Report Years Considered
 Figure 16. Long-lasting Interferon Sales Share by Manufacturers in 2024
 Figure 17. Global Long-lasting Interferon Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Long-lasting Interferon Players: Market Share by Revenue in Long-lasting Interferon in 2024
 Figure 19. Long-lasting Interferon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Long-lasting Interferon Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Long-lasting Interferon Sales Market Share by Country (2020-2031)
 Figure 22. North America Long-lasting Interferon Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Long-lasting Interferon Sales Market Share by Country (2020-2031)
 Figure 26. Europe Long-lasting Interferon Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Long-lasting Interferon Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Long-lasting Interferon Revenue Market Share by Region (2020-2031)
 Figure 34. China Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Long-lasting Interferon Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Long-lasting Interferon Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Long-lasting Interferon Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Long-lasting Interferon Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Long-lasting Interferon Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Long-lasting Interferon by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Long-lasting Interferon by Type (2020-2031)
 Figure 56. Global Long-lasting Interferon Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Long-lasting Interferon by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Long-lasting Interferon by Application (2020-2031)
 Figure 59. Global Long-lasting Interferon Price (US$/Unit) by Application (2020-2031)
 Figure 60. Long-lasting Interferon Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Interferon Market Research Report 2025
Global Interferons IFNs Market Research Report 2024
Interferon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Interferon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Natural Interferon IFN Market Insights Forecast to 2030
Global α Interferon Market Research Report 2024
Global Long acting Interferon Injection Market Research Report 2024
Global Interferon Injection Market Research Report 2024
Global Short acting Interferon Injection Market Research Report 2024
Global Long acting Peginterferon Market Research Report 2024
Global Interleukin Market Research Report 2025
Global Short acting Interferon Market Research Report 2024
Global Cytokines Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Interferon Alfa INN Market Research Report 2025
Global β Interferon Market Research Report 2024
Global Recombinant Human Interleukin Market Insights Forecast to 2030
Global Hepatitis C Interferon Market Research Report 2024
Global Cytokines as Cell Culture Supplements Market Research Report 2024
Global GMP Interleukin Market Insights Forecast to 2030
Global Recombinant Human Interferon Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions